A novel reactive oxygen species (ROS)-responsive nanoplatform can be successfully manufactured from a ROS-triggerable β-cyclodextrin material. Extensive in vitro and in vivo studies validate that this nanoscaled system may serve as a new drug delivery vehicle with well-defined ROS-sensitivity and superior biocompatibility. This nanocarrier can be used for ROS-triggered transport of diverse therapeutics and imaging agents.
Keywords: ROS-responsiveness; cyclodextrin; drug delivery; nanomedicine; tumor targeting.
© 2014 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.